DOSE OF REALITY: BIG PHARMA’S EGREGIOUS GLP-1, GENE, AND CELL THERAPY PRICES PROJECTED TO INCREASE HEALTH CARE COSTS FOR EMPLOYERS
Analysis Finds GLP-1 Blockbusters and “Multimillion-Dollar Gene Therapies”… Read More

Analysis Finds GLP-1 Blockbusters and “Multimillion-Dollar Gene Therapies”… Read More
Big Pharma Continues Raking in Expectation-Beating Profits and Revenue Fueled… Read More
More Brand Name Drug Makers Beat Wall Street Earnings After Hiking Prices This… Read More
Big Pharma Giants Top Wall Street Expectations After Hiking Prices on… Read More
Big Pharma Advertising Blitz Seeks to Protect Anti-Competitive Tactics That… Read More
Avik Roy Highlights How Increased USPTO-FDA Collaboration and Greater Scrutiny… Read More
Breaking Down the Facts on Drug Prices, Innovation, Patent Abuse… Read More
Research Article Explores Negative Implications of Proposal to Restrict Key… Read More
Research Column Explores Case Study in Common Patent Abuse Tactic That… Read More
Senate Judiciary Committee Puts Spotlight on Big Pharma’s Anti-Competitive… Read More
Senate Hearing Offers Opportunity to Highlight Market-Based Solutions to Hold… Read More
Analysis Showcases Egregious Scale of Big Pharma’s Patent Thickets on… Read More